These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31183390)

  • 1. Assessment of Salivary Levels of RANKL and OPG in Aggressive versus Chronic Periodontitis.
    Teodorescu AC; Martu I; Teslaru S; Kappenberg-Nitescu DC; Goriuc A; Luchian I; Martu MA; Solomon SM; Mârțu S
    J Immunol Res; 2019; 2019():6195258. PubMed ID: 31183390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
    Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
    J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
    Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
    J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL upregulation associated with periodontitis and Porphyromonas gingivalis.
    Wara-aswapati N; Surarit R; Chayasadom A; Boch JA; Pitiphat W
    J Periodontol; 2007 Jun; 78(6):1062-9. PubMed ID: 17539720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
    Giannopoulou C; Martinelli-Klay CP; Lombardi T
    Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients.
    Buduneli N; Biyikoğlu B; Sherrabeh S; Lappin DF
    J Clin Periodontol; 2008 Oct; 35(10):846-52. PubMed ID: 18727653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease.
    Bozkurt Doğan Ş; Öngöz Dede F; Ballı U; Sertoğlu E
    Cytokine; 2021 Aug; 144():155584. PubMed ID: 34034144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
    Armada L; Marotta Pdos S; Pires FR; Siqueira JF
    J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANKL and OPG mRNA level after non-surgical periodontal treatment.
    Dereka XE; Markopoulou CE; Fanourakis G; Tseleni-Balafouta S; Vrotsos IA
    Inflammation; 2010 Jun; 33(3):200-6. PubMed ID: 20033478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells.
    Fan R; Sun B; Zhang CF; Lü YL; Xuan W; Wang QQ; Yin XZ
    Chin Med J (Engl); 2011 Jul; 124(14):2162-6. PubMed ID: 21933620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RANKL-OPG system in clinical periodontology.
    Belibasakis GN; Bostanci N
    J Clin Periodontol; 2012 Mar; 39(3):239-48. PubMed ID: 22092994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-Inflammatory Cell Profile and Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin Expression in Persistent Apical Periodontitis after Root Canal Retreatment Failure.
    Estrela C; Decurcio Dde A; Silva JA; Batista AC; de Souza Lima NC; de Freitas Silva BS; de Souza JA; Souza Costa CA
    J Endod; 2016 Mar; 42(3):439-46. PubMed ID: 26806398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases.
    Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Berdeli A; Atilla G; McKay IJ; Hughes FJ; Belibasakis GN
    J Periodontal Res; 2007 Aug; 42(4):287-93. PubMed ID: 17559623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between T-helper cell polarization and the RANKL/OPG ratio in gingival tissues from chronic periodontitis patients.
    Bi CS; Sun LJ; Qu HL; Chen F; Tian BM; Chen FM
    Clin Exp Dent Res; 2019 Aug; 5(4):377-388. PubMed ID: 31944625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in chronic apical periodontitis].
    Fan R; Zhang CF; Gao Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 40(1):39-42. PubMed ID: 18278135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of local and systemic 25-hydroxy-vitamin D, RANKL, OPG, and TNF levels in patients with rheumatoid arthritis and periodontitis.
    Balci Yuce H; Gokturk O; Aydemir Turkal H; Inanir A; Benli I; Demir O
    J Oral Sci; 2017; 59(3):397-404. PubMed ID: 28904316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines.
    Duka M; Eraković M; Dolićanin Z; Stefanović D; Čolić M
    Mediators Inflamm; 2019; 2019():8325380. PubMed ID: 31011287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
    Mogi M; Otogoto J; Ota N; Togari A
    J Dent Res; 2004 Feb; 83(2):166-9. PubMed ID: 14742657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Enterococcus faecalis lipoteichoic acid on receptor activator of nuclear factor-κB ligand and osteoprotegerin expression in periodontal ligament fibroblasts.
    Zhao L; Chen J; Cheng L; Wang X; Du J; Wang F; Peng Z
    Int Endod J; 2014 Feb; 47(2):163-72. PubMed ID: 23710898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2 up-regulation is associated with RANKL/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages.
    Matarese G; Currò M; Isola G; Caccamo D; Vecchio M; Giunta ML; Ramaglia L; Cordasco G; Williams RC; Ientile R
    Amino Acids; 2015 Nov; 47(11):2447-55. PubMed ID: 26133738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.